Abstract
An abnormal, fast‐moving 5′‐nucleotide phosphodiesterase isozyme was found in 90.0% of 20 Malaysian patients with primary hepatoma and in 23.5% of 391 Malaysian patients with various malignant diseases; it was also discovered in 42.9% of 14 Malaysian and American patients with clinically active hepatitis B infection; in 16.7% of 18 healthy American blood bank donors who were positive for hepatitis B surface antigen (HBsAg); in 13.9% of 287 healthy Malaysian blood bank donors, some positive for HBsAg; and in none of 160 healthy American donors who were negative for HBsAg. A correlation of this abnormal isozyme with hepatoma and with infectious hepatitis B is clearly evident. Cancer 45:795‐798, 1980. Copyright © 1980 American Cancer Society
Cite
CITATION STYLE
Lei‐Injo, L. E., Tsou, K. C., Lo, K. W., Lopez, C. G., Balasegaram, M., & Ganesan, S. (1980). 5′‐Nucleotide phosphodiesterase isozyme‐V in health, in cancer, and in viral hepatitis. Cancer, 45(4), 795–798. https://doi.org/10.1002/1097-0142(19800215)45:4<795::AID-CNCR2820450431>3.0.CO;2-L
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.